ROUNDTABLE SURVEY RESULTS Our pilot program in 2015 was very successful. We distributed and collected surveys from all 6 of our Roundtable events, which were held in Boston, MA, Pittsburgh, PA. Los Angeles, CA and Dubl

First Page		Document Content
Date: 2016-01-26 12:45:27 Muscular dystrophy Biotechnology Duchenne muscular dystrophy Sarepta Therapeutics PTC Therapeutics Exon skipping Clinical trial BioMarin Pharmaceutical Draft:BMN 044 Draft:SRP-4044		ROUNDTABLE SURVEY RESULTS Our pilot program in 2015 was very successful. We distributed and collected surveys from all 6 of our Roundtable events, which were held in Boston, MA, Pittsburgh, PA. Los Angeles, CA and Dubl Add to Reading List Source URL: jettfoundation.org Download Document from Source Website File Size: 470,32 KB Share Document on Facebook

	Research Review No. 97. Mice with Exon 2 Duplication. The Studies: The authors of this study note that around 11% of cases of Duchenne Muscular Dystrophy (DMD) are due to a duplication in the dystrophin gene (1). Of th DocID: 1reMl - View Document
	Research Review No. 88. Recent exciting new Developments; A general oveview. The Studies: DocID: 1qUta - View Document
	Research Review NoNew techniques are racing ahead. The Studies: The studies to be discussed in this review confirm that working at the cutting edge as described in the previous Research Review (Nois procee DocID: 1pT0e - View Document
	Research Review No. 86. Recent exciting new Developments. A general oveview. Introduction: DocID: 1phvg - View Document
	ROUNDTABLE SURVEY RESULTS Our pilot program in 2015 was very successful. We distributed and collected surveys from all 6 of our Roundtable events, which were held in Boston, MA, Pittsburgh, PA. Los Angeles, CA and Dubl DocID: 1oCyv - View Document